In vitro susceptibility of Campylobacter jejuni to rokitamycin.
The susceptibilities of 100 clinical isolates of Campylobacter jejuni to rokitamycin, a new macrolide, and eight other oral antibiotics were tested by using a broth microdilution method. Rokitamycin demonstrated antibacterial activity that was higher than those of fosfomycin and the tetracyclines and comparable to those of erythromycin and clindamycin, whereas it was slightly less active than the quinolones.
Miyake
Y
Y
Department of Microbiology, Hiroshima University School of Dentistry, Japan.
Okada
M
M
Sasaki
M
M
Nagasaka
N
N
Suginaka
H
H
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002169:Campylobacter Infections / Q000382:microbiology; D002168:Campylobacter fetus / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015644:Miocamycin / Q000031:analogs & derivatives* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D015644:Miocamycin; C033383:rokitamycin